The Department of Public Health issued a final rule amending regulations under AAC 420-7-2 to add tianeptine to the Schedule II list of controlled substances. The rule also removes Epidiolex® from the list of Schedule V controlled substances. The Department also issued a notice announcing the addition of the seizure medication Cenobamate to Schedule V of the Controlled Substances List attached to regulations under AAC 420-7-2.
Also in Alabama. The Board of Medical Examiners has issued a proposed rule adopting regulations under AAC 540-X-26 to establish requirements for collaborative pharmacy practice. The rule would set forth requirements for the collaborative drug therapy management agreement, eligibility, limitations, physician standards, reporting, and renewal. A hearing is scheduled for November 2, 2020, in Montgomery. The final date for written comments to the state is November 4, 2020.
For more information, contact NACDS’ Leigh Knotts at 803-243-7207.